Hims vs Omada Health
Hims and Omada Health sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →
Omada Health
Best for: coaching bundled into the price rather than sold separately
Visit Omada Health →If you are choosing between Hims and Omada Health, price alone will not settle it. Hims leads our six-part score, 6.8 to 4.4. One of the two has an FDA warning letter on record, covered below.
Hims vs Omada Health price
Hims publishes $199 a month. Omada Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Hims lists semaglutide and tirzepatide; Omada Health does not name its drug.
On format, Hims prices compounded injections and brand-name pens, while Omada Health posts no priced format.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
Hims lists 50 states, and Omada Health does not publish where it ships.
Pricing
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
Omada Health
Pricing not publicly listed.
What each price covers
Hims' price also covers the medication itself, which Omada Health does not claim.
Omada Health's price also covers coaching, which Hims does not claim.
Hims is silent on shipping and lab work.
Omada Health is silent on the clinician visit, the medication itself, shipping and lab work.
That matters most for the drug: unless Omada Health confirms otherwise, budget for medication on top of its listed price.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Omada Health
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, Hims scores 6.8 and Omada Health 4.4 out of 10.
Hims is stronger on effectiveness (10.0 vs 5.0), user experience (8.0 vs 5.0), trust & safety (7.0 vs 4.0) and accessibility (10.0 vs 5.0).
Omada Health is stronger on support (5.0 vs 3.0).
Value is within half a point.
Hims
6.8/10
Omada Health
4.4/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Omada Health has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hims | Omada Health |
|---|---|---|
| Starting Price | $199/mo | Not published |
| Features | 2 features | ✓8 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →About Omada Health
Nothing about the core program carries a transparent cash price, since employers and plans are the channel. Late in 2025 Omada added prescribing and medication management for GLP-1s, handled by clinicians trained in obesity care and available across all 50 states, with behavioral support running before treatment, during it and after. Separately, GLP-1 Flex Care rolls out in 2026 and lets a member buy the drug through cash-pay channels while Omada supplies the oversight. Diabetes and hypertension sit alongside weight health in its behavior-change catalog.
Read our full Omada Health review →Pros & Cons
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Omada Health
What we like
- The monthly price includes coaching
- We found no FDA warning letters issued to Omada Health
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Hims wins this one, 6.8 to 4.4, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. Omada Health fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Choose Omada Health if…
You want coaching bundled into the price rather than sold separately.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Luvo Health
Moving between compounded and brand without changing seller
From $249/mo
Get started →Strut Health
Semaglutide at $99/month, 48% below the typical price
From $99/mo
Get started →Enhance MD
Knowing which pharmacy fills the vial: it names Tru Meds Rx
From $169/mo
Get started →Hims vs Omada Health: FAQ
Close alternatives to Hims and Omada Health
- Hims vs Hers
- Hims vs Care Bare Rx
- Hims vs Concierge MD LA
- Hims vs Corsica Health
- Omada Health vs Embody
- Omada Health vs TrimRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.